Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2017
Method for Measurement of Peroxisomal Very Long-Chain Fatty Acid Beta-Oxidation and De Novo C26:0 Synthesis Activity in Living Cells Using Stable-Isotope Labeled Docosanoic AcidMalu-Clair van de Beek, Inge M E Dijkstra, Stephan Kemp
Pharmacology & Therapeutics|June 19, 2026
C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophyYorrick R J Jaspers, Inge M E Dijkstra, Marc Engelen, et al.
Biochimica Et Biophysica Acta|December 16, 2014
Enzymatic characterization of ELOVL1, a key enzyme in very long-chain fatty acid synthesisMartin J A Schackmann, Rob Ofman, Inge M E Dijkstra, et al.
Plos One|August 23, 2012
Bezafibrate for X-linked adrenoleukodystrophyMarc Engelen, Luc Tran, Rob Ofman, et al.
Molecular Genetics and Metabolism|April 13, 2016
Pathogenicity of novel ABCD1 variants: The need for biochemical testing in the era of advanced geneticsMartin J A Schackmann, Rob Ofman, Björn M van Geel, et al.
Journal of Inherited Metabolic Disease|December 20, 2024
Altered lipid profile and reduced neuronal support in human induced pluripotent stem cell-derived astrocytes from adrenoleukodystrophy patientsRoberto Montoro Ferrer, Yorrick R J Jaspers, Inge M E Dijkstra, et al.
EMBO Molecular Medicine|February 19, 2010
The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophyRob Ofman, Inge M E Dijkstra, Carlo W T van Roermund, et al.
Frontiers in Cell and Developmental Biology|September 9, 2020
Comparison of the Diagnostic Performance of C26:0-Lysophosphatidylcholine and Very Long-Chain Fatty Acids Analysis for Peroxisomal DisordersYorrick R J Jaspers, Sacha Ferdinandusse, Inge M E Dijkstra, et al.
Biochimica Et Biophysica Acta|July 19, 2016
CYP4F2 affects phenotypic outcome in adrenoleukodystrophy by modulating the clearance of very long-chain fatty acidsCatherine E van Engen, Rob Ofman, Inge M E Dijkstra, et al.
Journal of Inherited Metabolic Disease|March 27, 2012
Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongationMarc Engelen, Martin J A Schackmann, Rob Ofman, et al.
Pageof 3